Dimensional Fund Advisors
NERV icon

Dimensional Fund Advisors’s Minerva Neurosciences NERV Stock Holding History

Dimensional Fund Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,779
Closed -$281K – 3543
2021
Q4 		$281K Sell
43,779
-48,728
-53% -$459K ﹤0.01% 3287
2021
Q3 		$1.29M Sell
92,507
-40,928
-31% -$616K ﹤0.01% 2987
2021
Q2 		$2.48M Sell
133,435
-2,591
-2% -$55.8K ﹤0.01% 2818
2021
Q1 		$3.18M Sell
136,026
-5,704
-4% -$143K ﹤0.01% 2720
2020
Q4 		$2.65M Sell
141,730
-5,493
-4% -$138K ﹤0.01% 2728
2020
Q3 		$3.75M Sell
147,223
-15,040
-9% -$407K ﹤0.01% 2548
2020
Q2 		$4.69M Sell
162,263
-26,571
-14% -$1.56M ﹤0.01% 2498
2020
Q1 		$9.1M Sell
188,834
-14,748
-7% -$890K ﹤0.01% 2163
2019
Q4 		$11.6M Buy
203,582
+418
+0.2% +$18.4K ﹤0.01% 2291
2019
Q3 		$12.6M Sell
203,164
-2,972
-1% -$168K ﹤0.01% 2248
2019
Q2 		$9.28M Sell
206,136
-3,411
-2% -$171K ﹤0.01% 2420
2019
Q1 		$13.2M Buy
209,547
+9,285
+5% +$558K 0.01% 2277
2018
Q4 		$10.8M Buy
200,262
+3,685
+2% +$270K ﹤0.01% 2302
2018
Q3 		$19.7M Buy
196,577
+147,697
+302% +$11.1M 0.01% 2120
2018
Q2 		$3.23M Buy
48,880
+14,057
+40% +$854K ﹤0.01% 2770
2018
Q1 		$1.74M Buy
34,823
+26,698
+329% +$1.28M ﹤0.01% 2890
2017
Q4 		$393K Buy
+8,125
New +$403K ﹤0.01% 3126

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's NERV Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of Minerva Neurosciences (NERV) in Q1 2022, closing a stake of 43,779 shares — an estimated $281K sold.

Dimensional Fund Advisors first reported a position in NERV in Q4 2017 and held it in 17 quarters. The position peaked at $19.7M in Q3 2018. 33 funds tracked by Wall St. Rank hold NERV as of Q1 2022.

  • Dimensional Fund Advisors reported no remaining Minerva Neurosciences position as of Q1 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 43,779 Minerva Neurosciences shares in Q1 2022, an estimated $281K.
  • Dimensional Fund Advisors first reported a position in Minerva Neurosciences in Q4 2017 and held it in 17 quarters.
  • Dimensional Fund Advisors's Minerva Neurosciences position peaked at $19.7M in Q3 2018.
  • 33 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.